Pulse Biosciences (PLSE) Current Assets (2015 - 2025)

Pulse Biosciences' Current Assets history runs 11 years deep, the most recent figure standing at $83.4 million for Q4 2025.

• In Q4 2025, Current Assets fell 30.16% year-over-year to $83.4 million; the TTM figure through Dec 2025 stood at $83.4 million (down 30.16% YoY), while the FY2025 annual figure was $83.4 million, down 30.16% from the prior year.
• Current Assets was $83.4 million for Q4 2025 at Pulse Biosciences, down from $97.2 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $120.9 million in Q1 2025 to a low of $22.2 million in Q1 2022.
• Historically, Current Assets has averaged $64.1 million across 5 years, with a median of $60.9 million in 2021.
• The sharpest annual moves came in 2022 and 2025: Current Assets sank 64.24% in 2022, then surged 297.08% in 2025.
• A 5-year view of Current Assets shows it stood at $45.3 million in 2021, then jumped by 37.11% to $62.1 million in 2022, then retreated by 27.06% to $45.3 million in 2023, then soared by 163.52% to $119.4 million in 2024, then plunged by 30.16% to $83.4 million in 2025.
• The last three Current Assets figures came in at $83.4 million (Q4 2025), $97.2 million (Q3 2025), and $108.2 million (Q2 2025), per Business Quant data.